Sustained release, and comfortable opthalmic composition and method for ocular therapy
US6486208B1 · kind B1 · utility
13Cited by
1References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2001 |
| Grant date | Nov 26, 2002 |
| Priority date | — |
| Expiry date | Mar 15, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to reduced stinging, sustained release ophthalmic formulations and the method of treatment comprising administering such formulations topically to the eye when in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.